Aurobindo launches Adquey, enters US dermatology market
Aurobindo Pharma subsidiary Acrotech Biopharma has launched Adquey (difamilast) in the US, the company's first novel dermatology drug. The non-steroidal topical ointment treats mild-to-moderate atopic dermatitis in adults and children aged two…
